AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novel Coronavirus Treatment

909.466

-3.763-0.41%

Number of Gainers:9

Number of Losers:6

Number of Flat:17

PE:- -

High:915.545

Open:915.545

Low:905.057

Close:913.277

Volume:9.85M

Turnover:95.87M

Market Cap:236.49B

Float Cap:183.18B

Loading ...

BUZZ-ASX shares of Mesoblast jump on FDA meeting plans, Phase 3 study update

American Tower (AMT): Evaluating Valuation After Raised 2025 Outlook and Strong Q3 Performance

Simply Wall St.

SNEF Marks 45 Years as the Voice of Employers in Singapore's Tripartite System

Morgans’ top large-cap picks for November 2025

BUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division

ResMed CFO Sells Shares

MT Newswires Live

ASX Biggest Losers

MT Newswires Live

ASX Midday Sector Update: Information Technology Stocks Rise, Healthcare Down

MT Newswires Live

Cynata Therapeutics' Three Active Programs Expected to Deliver 'Major' Catalysts Over Next Quarters, Says Euroz Hartleys

MT Newswires Live

American Tower (AMT) Lifts Guidance on AI-Driven Data Center Demand but Is Growth Sustainable?

Simply Wall St.

ResMed on Track for Longest Losing Streak Since May 2022 -- Data Talk

‘Third world’: Coles exec fumes at crime surge

The West Australian

Will Woolworths (ASX:WOW) Prioritize E-Commerce Over Core Categories Amid Performance Hurdles?

Simply Wall St.

Australian Shares Flat; ANZ Group Flags Net After-Tax Charge of Over AU$1 Billion in Fiscal H2

MT Newswires Live

Coles Partners with OpenAI to Deploy ChatGPT Enterprise Across Workforce

BUZZ-Australia's CSL set for worst week in 2 months on delaying spin-off

Coles' Superior Growth Justifies Higher Valuation -- Market Talk

Cynata Therapeutics Ltd-September 2025 Quarterly Activity Report and Appendix 4C

THOMSON REUTERS

Uscom Ltd-Quarterly Activities/Appendix 4C Cash Flow Report

THOMSON REUTERS

Atomo Diagnostics Ltd-Chair's Address to Shareholders

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7501/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":909.5135,"timestamp":1762739038161,"preClose":913.27673,"halted":0,"volume":9854127,"delay":0,"changeRate":-0.004121,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-3.763245,"latestTime":"11-10 12:43:58 AEDT","open":915.5452,"high":915.5452,"low":905.0574,"amount":95866111,"amplitude":0.011484,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1762750800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762729200000,1762750800000]],"turnoverRate":0.000685,"increases":9,"decrements":7,"flats":16,"marketCap":236494324854.25,"floatMarketCap":183177383227.58594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":915.5452,"amplitude":0.011484,"preClose":913.27673,"low":905.0574,"latestPrice":909.4656,"volume":9854187,"delay":0,"open":915.5452,"prevYearClose":1117.913,"prevWeekClose":913.277,"prevMonthClose":914.468,"prevQuarterClose":950.171,"fiveDayClose":902.484,"twentyDayClose":972.908,"sixtyDayClose":1133.772,"secType":"PLATE","market":"AU","turnoverRate":0.000685,"marketCap":236495047798.25,"floatMarketCap":183178100539.58594,"timestamp":1762739039535,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":9,"down":6,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581791230","title":"BUZZ-ASX shares of Mesoblast jump on FDA meeting plans, Phase 3 study update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581791230","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581791230?lang=en_us&edition=fundamental","pubTime":"2025-11-05 08:33","pubTimestamp":1762302792,"startTime":"0","endTime":"0","summary":"BUZZ-ASX shares of Mesoblast jump on FDA meeting plans, Phase 3 study update** ASX-listed shares of inflammatory disease drug maker Mesoblast MSB.AX rise as much as 2.3% to A$2.465, their biggest intra-day percentage gain since October 21** MSB says co will meet with U.S. Food & Drug Administration in early December to discuss data on opioid reduction ** Says co will also discuss cessation from its first Phase 3 study  of rexlemestrocel-L in patients with chronic low back pain ** Stock third-biggest percentage gainer in the S&P/ASX 200 Health care sub-index ** Stock currently up 1% at A$2.435** Stock down 22.3% this year, including the day's move  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL4N3WH01D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7067","BK7501","BK7508"],"gpt_icon":0},{"id":"2581168437","title":"American Tower (AMT): Evaluating Valuation After Raised 2025 Outlook and Strong Q3 Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2581168437","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581168437?lang=en_us&edition=fundamental","pubTime":"2025-11-05 07:47","pubTimestamp":1762300058,"startTime":"0","endTime":"0","summary":"American Tower (AMT) caught attention after releasing its third-quarter results, which showed a clear uptick in sales and net income. The company also raised its 2025 earnings outlook, reflecting management’s confidence in the face of ongoing industry challenges.\nSee our latest analysis for American Tower.\nWhile American Tower’s revenue and net income have climbed, the broader story for investors is more nuanced. Despite the upbeat earnings and a fresh round of share buybacks, the company’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/american-tower-amt-evaluating-valuation-after-raised-2025-ou","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/american-tower-amt-evaluating-valuation-after-raised-2025-ou","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AMT","BK4219","AMT.AU","BK4585","BK7501","BK4581","BK4084","DCF","BK7007","BK4588","BK4534","BK4554"],"gpt_icon":0},{"id":"2580032412","title":"SNEF Marks 45 Years as the Voice of Employers in Singapore's Tripartite System","url":"https://stock-news.laohu8.com/highlight/detail?id=2580032412","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580032412?lang=en_us&edition=fundamental","pubTime":"2025-11-04 13:30","pubTimestamp":1762234200,"startTime":"0","endTime":"0","summary":"SINGAPORE, Nov. 4, 2025 /PRNewswire/ --The Singapore National Employers Federation  commemorated 45 years as the voice of employers in Singapore's tripartite system at the SNEF45 Employers' Summit on 4 November 2025. Themed Forging the Future of Work Together, the summit reflects SNEF's long-standing commitment to advancing tripartism and championing employers' interests. At the event, SNEF also announced the SNEF Advisory, Resource, and Consultancy Centre and the SNEF Research Advisory Panel to better serve our members in workforce and workplace transformation as well as to advise and collaborate with SNEF on policy research.Deputy Prime Minister and Minister for Trade and Industry Mr Gan Kim Yong with Tripartite Leaders and SNEF Council. Celebrating 45 Years of Tripartite Partnership and Progress. The SNEF Research Advisory Panel consists of 5 distinguished academics who will provide expertise and indepen","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2812792/Picture_2.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2812792/Picture_2.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/snef-marks-45-years-as-the-voice-of-employers-in-singapores-tripartite-system-302603517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","BK4107","IE00BN8TJ469.HKD","BK4585","EIG","LU2360032135.SGD","RAP.AU","LU2125154935.USD","BK4135","ARCC","IE00BBT3K403.USD","BK7094","BK7095","BK7501","LU2125154778.USD","BK4588","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2580768932","title":"Morgans’ top large-cap picks for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580768932","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580768932?lang=en_us&edition=fundamental","pubTime":"2025-11-04 10:35","pubTimestamp":1762223757,"startTime":"0","endTime":"0","summary":"After two consecutive years of aggregate earnings decline, the ASX 200 is. forecast to return to growth, with earnings expected to rise 5.7% in FY26 and. we see this as limiting multiple expansion rather than signalling downside price. risk. But concentration risk and ongoing macroeconomic tremors will continue to. see significant stock divergence, and investors will need to remain nimble and on. Although the financial year-end of most Australian businesses is the end of June,many important listed companies report to the end of March and September.This month, we update our large-cap Best Ideas, adding Aristocrat and removing Treasury Wine Estates, WiseTech and Light & Wonder.CSL is looking to simplify operations and reduce complexity to enhance agility and performance. CSL will hold a Capital Markets Day in the US from November 4–6, 2025, to provide further details on its strategy, this will be important to help investors regain confidence.oil prices, if any volatility were to unfold i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/morgans-top-large-cap-picks-for-november-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/morgans-top-large-cap-picks-for-november-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU1244550494.USD","LU2237443382.USD","BK7097","CSL.AU","TWE.AU","NST.AU","BK7501","LU2237443978.SGD","BK7505","LU0310799852.SGD","LU0211328371.USD","RMD.AU","BK4532","LU2237443622.USD","BK7508","BK7007","LU1267930490.SGD","BK4504","BK7506","LU0823411888.USD","LNW.AU","BK7511","TGT","LU1244550221.USD","ALL.AU","LU0310800965.SGD","BK7063","BK4155","BK7155","LU0128525689.USD","BK7503","LU1267930227.SGD","LU1244550577.SGD","LU0052756011.USD","BK4533","LU0211327993.USD","AMC.AU","BK7099","BK4596","BK4114","GMG.AU","BK4597","BK7078","WTC.AU","BK4588","BK4585","BK7067","WDS.AU","BK7016","BK7142"],"gpt_icon":0},{"id":"2580790342","title":"BUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division","url":"https://stock-news.laohu8.com/highlight/detail?id=2580790342","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580790342?lang=en_us&edition=fundamental","pubTime":"2025-11-04 10:27","pubTimestamp":1762223244,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL up as Morgan Stanley remains positive on plasma division   ** Shares of CSL CSL.AX rise as much as 1.8% to A$178.47, set to snap two straight sessions of losses** Morgan Stanley sees a favourable medium- to long-term outlook in demand for immunoglobulin , a component found in blood plasma** Notes distributed volume of Ig in the U.S. has increased strongly over time, with high single-digit annual growth recorded over the past 3, 10 and 15 years** Brokerage sees headroom for growth in the U.S. across various therapies, including cell therapy; also sees scope for increased in ex-U.S. markets** MS sees potential for Ig outlook alongside yield initiatives to support a gross margin recovery for CSL Behring, co's plasma segment** Brokerage retains \"overweight\" tag, price target A$248** Stock down 37.3% YTD, including the day's moves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL6N3WG05E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7511","BK7067","BK7508","BK7501"],"gpt_icon":0},{"id":"2580098229","title":"ResMed CFO Sells Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2580098229","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580098229?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:18","pubTimestamp":1762208321,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) Chief Financial Officer Brett Sandercock sold 3,000 shares on the New York Stock Exchange for $742,620 in total, according to a Tuesday filing with the Australian bourse.Following the sale of shares, Sandercock owns 146 million shares in the company, per the filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B5TLWC47.USD","RMD.AU","BK4585","LU0170899867.USD","LU2008162690.USD","XKO.AU","RMD","XJO.AU","BK4567","BK7501","BK4504","BK4082","BK7007","XAO.AU","LU2177674079.SGD","BK4548","BK4588"],"gpt_icon":0},{"id":"2580526887","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2580526887","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580526887?lang=en_us&edition=fundamental","pubTime":"2025-11-03 13:46","pubTimestamp":1762148804,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest losses on Monday.Lynas Rare Earths : 8%, AU$14.02Steadfast Group : 7%, AU$5.21Guzman y Gomez : 5%, AU$25.39ResMed : 4%, AU$37.83Iluka Resources : 4%, AU$6.63Neuren Pharmaceuticals : 4%, AU$20.95Silex Systems : 4%, AU$9.97Pinnacle Investment Management : 3%, AU$19.11Regis Resources : 3%, AU$6.25IGO : 3%, AU$5.22","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7069","GYG.AU","PNI.AU","IGO.AU","BK7506","BK7088","NEU.AU","ILU.AU","BK7062","BK7096","BK7501","RMD.AU","BK7508","BK7137","SLX.AU","BK7504","LYC.AU","RRL.AU","BK7507","BK7007","SDF.AU","BK7101","BK7095","BK7104"],"gpt_icon":0},{"id":"2580225960","title":"ASX Midday Sector Update: Information Technology Stocks Rise, Healthcare Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2580225960","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580225960?lang=en_us&edition=fundamental","pubTime":"2025-11-03 10:38","pubTimestamp":1762137520,"startTime":"0","endTime":"0","summary":"Information technology stocks advanced almost 1% at midday Monday. On Wall Street, the S&P 500 rose 0.3% and the Nasdaq Composite index rose 0.6%.ReadyTech Holdings  said it expects the 13,866 files originating from its hosted student management system, VETtrak, published by a cybercriminal to include contact information, financial details, tax file numbers, and other sensitive personal and health information. The company said it will identify and notify affected individuals depending on the categories of personal information involved.On the flip side, the healthcare sector fell almost 2%. The Melbourne Institute said its monthly inflation gauge rose in October, primarily influenced by higher recreation and housing-related prices. Annual headline inflation has edged slightly above the upper limit of the 2% to 3% target band.ResMed , whose shares fell over 4%, reported September quarter earnings of $2.37 per share, up from $2.11 a year earlier. Revenue for the three months ended Sept. 3","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","III","LU0128526141.USD","XBI","XLV","BK4137","LU0029874061.USD","BK4134","HCSG","RMD.AU","LABU","BK4585","BK4588","BK7501","RDY.AU","BK7016","BK7007"],"gpt_icon":0},{"id":"2580255089","title":"Cynata Therapeutics' Three Active Programs Expected to Deliver 'Major' Catalysts Over Next Quarters, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2580255089","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580255089?lang=en_us&edition=fundamental","pubTime":"2025-11-03 09:52","pubTimestamp":1762134736,"startTime":"0","endTime":"0","summary":"Cynata Therapeutics  continued to advance its clinical pipeline, with three active programs expected to deliver major catalysts over several quarters, according to a Friday note by Euroz Hartleys.The research firm added that the opportunity for CYP remains as \"strong\" as ever, as last year the US Food and Drug Administration approved its first-ever mesenchymal stem cell  therapy, which was subsequently priced at about $1.55 million per patient.The research firm believes that the approval has established both regulatory and commercial precedents, which are \"very positive\" for the MSC sector.Euroz Hartleys has maintained a speculative buy rating on Cyanata Therapeutics with a price target of AU$0.90.The company's shares fell 2% in recent Monday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LENZ","BK6507","MSC","NPW.SI","BK4575","BK4539","BK4150","BK6078","BK7067","BK4007","BK7508","CYP.AU","BK7501"],"gpt_icon":0},{"id":"2580404385","title":"American Tower (AMT) Lifts Guidance on AI-Driven Data Center Demand but Is Growth Sustainable?","url":"https://stock-news.laohu8.com/highlight/detail?id=2580404385","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580404385?lang=en_us&edition=fundamental","pubTime":"2025-11-02 09:29","pubTimestamp":1762046957,"startTime":"0","endTime":"0","summary":"American Tower recently reported third-quarter 2025 results that beat expectations, with revenue reaching US$2.72 billion and net income swinging to US$853.3 million, alongside an upward revision of its full-year financial guidance driven by robust data center and AI-related demand.\nSignificantly, the company addressed ongoing legal matters with Dish Wireless while highlighting record growth in adjusted funds from operations and continued momentum in both tower and data center leasing...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/american-tower-amt-lifts-guidance-on-ai-driven-data-center-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/american-tower-amt-lifts-guidance-on-ai-driven-data-center-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4587","BK4551","LYY.SI","AMT.AU","BK4543","BK4534","BK6051","BK4528","BK4554","BK4581","BK4588","BK7501","AI","BK4585","AMT","BK4023","BK4219","BK4084","BK7007"],"gpt_icon":0},{"id":"2580418237","title":"ResMed on Track for Longest Losing Streak Since May 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2580418237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580418237?lang=en_us&edition=fundamental","pubTime":"2025-11-01 03:18","pubTimestamp":1761938280,"startTime":"0","endTime":"0","summary":"ResMed Inc.  is currently at $246.55, down $5.71 or 2.26%. --Would be lowest close since June 2, 2025, when it closed at $244.03. --Currently down nine consecutive days; down 9.16% over this period. --Longest losing streak since May 3, 2022, when it fell for nine straight trading days. --Worst nine-day stretch since the nine days ending July 3, 2024, when it fell 11.19%. --Down 9.93% month-to-date; on pace for worst month since Aug. 2023, when it fell 28.23%. --Down 17.09% from its all-time closing high of $297.36 on Sept. 8, 2021. --Down 16.06% from its 52-week closing high of $293.73 on Aug. 22, 2025. --Up 20.54% from its 52-week closing low of $204.54 on April 8, 2025. --Traded as low as $239.41; lowest intraday level since May 6, 2025, when it hit $237.00. --Down 5.09% at today's intraday low; largest intraday percent decrease since April 8, 2025, when it fell as much as 5.24%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","RMD.AU","RMD","LU2177674079.SGD","BK4548","BK7007","BK4567","BK4588","BK7501","IE00B5TLWC47.USD","BK4082","LU0170899867.USD","LU2008162690.USD","BK4585"],"gpt_icon":0},{"id":"2580445268","title":"‘Third world’: Coles exec fumes at crime surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2580445268","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580445268?lang=en_us&edition=fundamental","pubTime":"2025-11-01 01:32","pubTimestamp":1761931941,"startTime":"0","endTime":"0","summary":"Coles says it’s like a “third world” country in one state, as a shocking amount of high value items are stolen by organised crime.","market":"nz","thumbnail":"https://images.thewest.com.au/publication/C-20541856/b9866f7acc9d6a070ad6fd52fb6be80f97bbe633-16x9-x0y192w2048h1152.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20541856/b9866f7acc9d6a070ad6fd52fb6be80f97bbe633-16x9-x0y192w2048h1152.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/coles-calls-out-crime-surge-in-key-state-c-20541856","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/coles-calls-out-crime-surge-in-key-state-c-20541856","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["XAO.AU","BK7040","BK7082","COL.AU","XJO.AU","XKO.AU","BK7501"],"gpt_icon":0},{"id":"2580041664","title":"Will Woolworths (ASX:WOW) Prioritize E-Commerce Over Core Categories Amid Performance Hurdles?","url":"https://stock-news.laohu8.com/highlight/detail?id=2580041664","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580041664?lang=en_us&edition=fundamental","pubTime":"2025-10-31 21:43","pubTimestamp":1761918235,"startTime":"0","endTime":"0","summary":"Woolworths Group Limited recently reported total group sales of A$18.48 billion for the first quarter of FY26, up 2.7% year-on-year, with e-commerce and B2B segments contributing most of the growth.\nDespite higher sales, CEO Amanda Bardwell noted performance was below the company's expectations due to weaker results in pet and baby products and a large decline in tobacco sales, even as e-commerce sales improved.\nWe’ll now examine how management’s cautious tone and focus on category...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/874687-main-header/1585186851010","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/874687-main-header/1585186851010"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-retailing/asx-wow/woolworths-group-shares/news/will-woolworths-asxwow-prioritize-e-commerce-over-core-categ","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-retailing/asx-wow/woolworths-group-shares/news/will-woolworths-asxwow-prioritize-e-commerce-over-core-categ","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","BK7040","BK4100","BK7501","WOW.AU","WOW"],"gpt_icon":0},{"id":"2579435278","title":"Australian Shares Flat; ANZ Group Flags Net After-Tax Charge of Over AU$1 Billion in Fiscal H2","url":"https://stock-news.laohu8.com/highlight/detail?id=2579435278","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579435278?lang=en_us&edition=fundamental","pubTime":"2025-10-31 13:47","pubTimestamp":1761889639,"startTime":"0","endTime":"0","summary":"Australian shares were flat with a positive bias at Friday's close, amid the US and China's one-year tariff truce.The S&P/ASX 200 was little changed to close at 8,881.9.Trump said the US now has acces","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XJO.AU","BK7508","BK7511","BK7135","BK7096","ANZ.AU","BK7007","MYX.AU","CBA.AU","BK7501","RMD.AU","XKO.AU"],"gpt_icon":0},{"id":"2579800654","title":"Coles Partners with OpenAI to Deploy ChatGPT Enterprise Across Workforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2579800654","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579800654?lang=en_us&edition=fundamental","pubTime":"2025-10-31 12:31","pubTimestamp":1761885065,"startTime":"0","endTime":"0","summary":"Coles Group Ltd. has announced a new collaboration with OpenAI, becoming the first major Australian retailer to deploy ChatGPT Enterprise at scale. The partnership will see Coles integrate OpenAI's advanced GPT-5 model across its corporate workforce, aiming to accelerate research, reduce administrative tasks, and enhance data-driven decision making. The rollout includes customised AI training for team members, with a full deployment planned for February 2026. Coles and OpenAI are also exploring innovative AI applications to improve both operational efficiency and the customer shopping experience, all underpinned by Coles' commitment to ethical and responsible AI use.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coles Group Ltd. publi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL3Tvmh0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7040","BK7501","COL.AU","BK7082"],"gpt_icon":0},{"id":"2579806144","title":"BUZZ-Australia's CSL set for worst week in 2 months on delaying spin-off","url":"https://stock-news.laohu8.com/highlight/detail?id=2579806144","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579806144?lang=en_us&edition=fundamental","pubTime":"2025-10-31 12:18","pubTimestamp":1761884337,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL set for worst week in 2 months on delaying spin-off** CSL CSL.AX slips 15.5% to A$179.77 so far this week; set for biggest weekly drop since week ended August 22** Biotech major n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL6N3WC07K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7067","BK7501","BK7511","BK7508"],"gpt_icon":0},{"id":"2579840014","title":"Coles' Superior Growth Justifies Higher Valuation -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2579840014","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579840014?lang=en_us&edition=fundamental","pubTime":"2025-10-31 11:11","pubTimestamp":1761880260,"startTime":"0","endTime":"0","summary":"0311 GMT - Coles' bulls at Macquarie see the Australian supermarket operator's superior growth justifying its higher valuation relative to its largest rival. The investment bank's analysts tell clients in a note that Coles' 4.6% comparable sales growth over its fiscal first quarter was indicative of further market-share gains. Growth was two or three times the pace at which Woolworths grew sales over the same period, they observe. The analysts say that Coles' stores appear to be benefiting from the company's investment in fulfillment centers. They will be keen for industry feedback through the key Christmas trading period. Macquarie lifts its target price by 2.8% to A$26.10 and maintains an outperform rating. Shares are down 1.0% at A$21.89. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPN","BK7082","BK7501","COL.AU","BK7040"],"gpt_icon":0},{"id":"2579140481","title":"Cynata Therapeutics Ltd-September 2025 Quarterly Activity Report and Appendix 4C","url":"https://stock-news.laohu8.com/highlight/detail?id=2579140481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579140481?lang=en_us&edition=fundamental","pubTime":"2025-10-31 10:36","pubTimestamp":1761878184,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nTUEBYY3RW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","CYP.AU","BK7067"],"gpt_icon":0},{"id":"2579102694","title":"Uscom Ltd-Quarterly Activities/Appendix 4C Cash Flow Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2579102694","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579102694?lang=en_us&edition=fundamental","pubTime":"2025-10-31 07:35","pubTimestamp":1761867350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE4NCNPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7007","UCM.AU"],"gpt_icon":0},{"id":"2579310573","title":"Atomo Diagnostics Ltd-Chair's Address to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2579310573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579310573?lang=en_us&edition=fundamental","pubTime":"2025-10-31 05:55","pubTimestamp":1761861322,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE5WL3D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7007","AT1.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":109,"code":"91000000","status":"200"}]}}